BioSpace News Archive

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Healthcare Conference on Thursday, June 10, 2021, at 5:30 PM ET.

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), announced that the companies signed an exclusive contract to scale production of OliX’s OLX104C, an investigational RNAi therapeutic in development for the treatment of androgenic alopecia.

The report highlights the trends prevalent in the global hemostats market and the factors driving the market along with those that act as deterrents to its growth.

The increasing prevalence of cancer and growing inclination toward nuclear scans for accurate diagnosis are the key forces driving the market growth.

Johnson & Johnson will host a conference call for investors at 8:30 a.m. on Wednesday, July 21st to review second-quarter results.

Zeus Industrial Products, Inc., the global leader in advanced polymer solutions, announced that it has finalized an agreement to integrate CathX Medical Inc. into its organization.

PainQx, Inc. (www.painqx.com), is pleased to announce it has been awarded a Defense Health Agency (www.health.mil) Phase II SBIR contract.

Despite global disruptions to family planning services due to the Covid-19 pandemic, WomanCare Global Trading CIC and Shanghai Dahua Pharmaceutical Co., Ltd. are proud to announce a price reduction of Levoplant, a two-rod contraceptive implant prequalified by the World Health Organization for up to three years of use.

VisionQuest Biomedical Inc. announces that it has been awarded a $2M grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to commercialize ASPIRE, a device that uses artificial intelligence to improve the diagnosis of cerebral malaria.

Medline and Spectramed announced an exclusive collaboration to optimize patient outcomes around the treatment of dysphagia, the difficulty of swallowing, and related muscle weakness.